Case study
Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program
Switching from one vaccine product to another can have a significant impact on a country’s budget. For Palestine’s rotavirus vaccination program, a switch paid off.
This brief describes an economic analysis conducted by PATH in partnership with the Rostropovich-Vishnevskaya Foundation and the Palestinian Ministry of Health to assess the economic implications of Palestine’s switch from ROTARIX to ROTAVAC.
Authors
Languages
- Arabic
- English
- Russian
- French: Implications Économiques du Changement de Vaccin Antirotavirus dans le Programme de Vaccination de la Palestine
Publication year
2020
Type
Case study
Categories
- Programme management
Diseases
- Rotavirus
Organisations
- PATH
Tags
- Planning, budgeting and financing
PORTFOLIO-LESSONS
This resource appears in the following Hot Topic page:
The resource is included in the following table:
